All
Opdivo Plus Chemo Shows 5-Year Efficacy in Gastric, GEJ and Esophageal Cancer
Among patients with advanced gastric and GEJ cancer, or esophageal adenocarcinoma, treatment with first-line Opdivo and chemo demonstrated deep responses.
SHR-1701 Combo Reduces Chemo-Related Myelosuppression in Gastric/GEJ Cancer
SHR-1701 plus chemo suppressed chemo-associated myelosuppression in patients with HER2-negative gastric or gastroesophageal junction adenocarcinoma.
Afinitor Plus Somatuline Prolongs Survival in GEP-NETs
Afinitor plus Somatuline showed an improved survival compared with Afinitor monotherapy in patients with gastroenteropancreatic neuroendocrine tumors.
Matching Patient Needs with Oncologists’ Strengths in Cancer Care
Following a lung cancer diagnosis, I learned that it is important to ask oncologists thoughtful questions to know if they are the best doctor for my needs.
The FDA Accepts a BLA for RP1 Plus Opdivo in Advanced Melanoma
The FDA has accepted a BLA for treatment with RP1 in combination with Opdivo for patients with advanced melanoma who have progressed on prior therapy.
Driving Awareness, Action and Empowerment During Cervical Cancer Awareness Month
Dr. Ritu Salani discussed Cervical Cancer Awareness Month, highlighting what patients with this disease should be aware of as well as prevention tactics.
Feeding Souls: A Cancer Journey Through the Lens of Food
I've learned that cooking for friends during their cancer journey is a way to express love and support, even if it doesn't cure them.
With Cancer in Remission, What is the New Normal for Princess Kate?
CURE® spoke with experts about what life is like for patients with cancer when their disease is in remission.
Rising from Ashes: Rediscovering Myself After Multiple Myeloma
I rediscovered myself through community, writing, music and cooking after my journey with multiple myeloma.
Understanding the Concept of MRD for Patients With Cancer
Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it relates to recurrence in patients.
An Expert Expands on What Drives ‘Exceptional’ Responses to RCC Treatment
Dr. David A Braun delved into detail on the molecular factors driving exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.
Understanding the Challenges of CAR T-Cell Therapy Treatment in R/R NHL
Yescarta continued to demonstrate durable responses after a median follow-up of more than five years in patients with R/R indolent non-Hodgkin lymphoma.
The Power of Unity: Why the Lung Cancer Genetics Study Matters
The Lung Cancer Genetics Study, a collaboration between lung cancer advocacy organizations, aims to explore the genetics of lung cancer
Glucarpidase May Improve Renal Outcomes in Lymphoma, Leukemia
Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes following glucarpidase treatment.
My New Year’s Resolution After A Testicular Cancer Diagnosis
My New Year's resolutions have evolved from seeking external goals to embracing personal growth and appreciating each day.
Improving Efficacy, Minimizing Toxicity in Chemotherapy For Breast Cancer
An expert spoke with CURE about providers’ “two-fold goal” when using chemotherapy to treat patients with breast cancer.
Missed Chemotherapy Cycles Reduces Survival in Head and Neck Cancers
Missing weekly cisplatin cycles was associated with worse OS in patients with head and neck cancers, particularly for those with p16-negative tumors.
IMM-1-104 Treatment May Improve Responses in Pancreatic Cancer
A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic cancer.
Kate, Princess of Wales, ‘Got So Attached’ to Her Port During Cancer Treatment
An expert spoke with CURE® about the emotional bonds that can develop while treating patients with cancer.
Waiting for Results After My CLL Diagnosis
Waiting for results of a CT scan after a cancer diagnosis is agonizing, as I anxiously await news on whether my disease has returned.
Subcutaneous Dacogen Elicits Responses Among Some With Myelofibrosis
Ten days of subcutaneous Dacogen resulted in responses among a third of patients with myelofibrosis.
The Significance of the Subcutaneous Opdivo FDA Approval in Solid Tumors
Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means for those with solid tumors.
Long-Term Patient Care Focuses on Precision-Based Therapy in Breast Cancer
Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.
PH284 Nasal Spray May Improve Feelings of Hunger in Cancer Cachexia
PH284 increased feelings of hunger and was safe in patients with cancer cachexia, which results in significant weight loss.
How Can Psychedelics Affect Patients With Cancer?
CURE spoke with an expert about how psychedelics such as psilocybin may impact patients’ mental health.
Kate, Princess of Wales, Enters ‘Survivorship Care Period’ of Cancer Journey
An expert explains the new phase of Princess Kate’s cancer journey as she enters remission.
FDA Approves Datroway for HR+, HER2- Breast Cancer
Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy.
Carrying the Torch: From Colorectal Cancer Survivor to Advocate
As someone who has overcome colorectal cancer, I reflect on the support I received from others and vow to continue their legacy of advocacy.
‘Nanny 911’ Star Deborah Finck Died, Danielle Fishel Completed Radiation and More
From the death of a TikTok influencer to an update from a “Boy Meets World” star, here is this week’s news.
Improving Treatment Access to Innovative Therapies in Breast Cancer
Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.
